简体中文 | 繁體中文 | English

Health and Pharmaceutical Press Releases

2022-03-29 10:08 Takeda’s TAKHZYRO® (lanadelumab) Approved in Japan for Prophylaxis Against Acute Attacks of Hereditary Angioedema (HAE)
2022-03-29 10:06 Galderma to Present New Clinical Data and High Patient Satisfaction Across Their Portfolio of Dermal Fillers, Collagen Biostimulators and Liquid Neuromodulators at AMWC 2022
2022-03-28 21:22 New Study Shows Virtual Bronchoscopic Navigation With Fused Fluoroscopy and Vessel Mapping Using Broncus Archimedes System is Safe and Effective in Obtaining High Biopsy Yield in Lung Tumors
2022-03-28 16:58 Tanner Pharma Increases Europe-Based Inventory of Leukine® to Expand Availability and Enhance Response to Potential Radiation Exposure Due to the Ongoing Conflict in Ukraineation Exposure Due to the Ongoing Conflict in Ukraine
2022-03-28 13:37 Publication of definitive end result for Vifor Pharma tender offer
2022-03-28 09:26 Galderma to Highlight Latest Science and Innovation Across Its Product Portfolio at the 2022 AAD Annual Meeting
2022-03-25 21:09 Galderma to Highlight Latest Science and Innovation Across Its Product Portfolio at the 2022 AAD Annual Meeting
2022-03-25 09:31 ViiV Healthcare announces label update for its long-acting HIV treatment, Cabenuva (cabotegravir, rilpivirine), to be initiated with or without an oral lead-in period
2022-03-23 15:28 Alchemab Selected to Access NVIDIA Cambridge-1 Supercomputer to Advance Machine Learning Enabled Antibody Discovery
2022-03-23 14:54 Publication of provisional end result for Vifor Pharma tender offer: Participation rate of 94 percent
2022-03-21 18:32 Ingersoll Rand Commits $1 Million in Ukraine Humanitarian Aid
2022-03-18 17:21 More Than Half of Physicians Have Been Asked By Patients for an Unapproved COVID-19 Treatment
2022-03-18 10:43 Cognitive Function Test for Normal Subjects Developed in Japan, an Advanced Super-Aging Nation, Article Published in International Medical Journal (Dementia and Geriatric Cognitive Disorders)
2022-03-18 10:16 Frazier Life Sciences Closes $987 Million Venture Fund to Invest in Companies Developing Novel Biopharmaceuticals
2022-03-17 16:41 Exscientia to Report Fourth Quarter and Year End 2021 Financial Results on March 23, 2022
2022-03-17 10:06 Aleph Farms Reveals Its Strategy to Replace the Whole Cow as an Alternative to Intensive Cattle Farming
2022-03-17 09:50 Jardiance® (empagliflozin) Phase III EMPA-KIDNEY trial will stop early due to clear positive efficacy in people with chronic kidney disease
2022-03-16 14:50 JSR Life Sciences’ Amsphere A3 Integrated into the Commercial Manufacturing of FDA-Approved Antibody Therapy
2022-03-16 11:33 Zayed Sustainability Prize Opens Submissions for 2023 Cycle
2022-03-15 19:14 Dexcom G7 Receives CE Mark – Next-Generation Continuous Glucose Monitoring System to Revolutionize Diabetes Management